Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04823169
Other study ID # CHM-2020/S11/09
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 22, 2021
Est. completion date September 22, 2023

Study information

Verified date March 2021
Source Centre Hospitalier le Mans
Contact Christelle JADEAU
Phone 02 44 71 07 81
Email cjadeau@ch-lemans.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The definitive treatment of disabling metatarsalgia requires surgery. In recent years, a percutaneous technique has been developed, the "Distal Metatarsal Mini-invasive Osteotomy" (DMMO). It consists of performing extra-articular osteotomies that are not osteosynthesized and maintained during the time of bone consolidation by a dressing and specific offloading footwear.The patient is encouraged to resume walking immediately after the procedure, as full plantar support is an integral part of the surgical concept. The goal is to actively modify the distribution of all metatarsal supports by the pressure exerted on the ground during walking and by tendon tensions, in order to reduce forefoot deformities. DMMO offers many advantages over traditional techniques, but it remains a painful forefoot surgery in the short term despite the systematic use of analgesics and the wearing of a dedicated therapeutic shoe. The study will seek to identify the predictive character of podobarometric parameters at walking (D+7 and D+30 post-op), between patients who will require a palliative solution versus those who will not (D+90)


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date September 22, 2023
Est. primary completion date September 22, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult person - Affiliated or beneficiary of a statutory social insurance scheme - Free ans informed consent - Following foot surgery like DMMO only or DMMO and hallux valgus Exclusion Criteria: - Minor or legally protect adult - Amputation disturbing the natural course of the step - Osteoarticular diseases/sequelae affecting walking and/or balance - Neuromuscular diseases/sequelae affecting walking and/or balance - Vestibular disorders affecting balance - Patients requiring a walking aid (e.g., walker) - Pregnant woman - Patient with dementia who are unable to follow verbal instructions

Study Design


Related Conditions & MeSH terms

  • Distal Metatarsal Mini-invasive Osteotomy (DMMO)

Intervention

Other:
podobarometry
podobarometric measures on day 7 and day 30

Locations

Country Name City State
France Centre Hospitalier Du Mans Le Mans

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier le Mans

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary podobarographic parameters (plantar pressures) predictive of the need for a palliative foot orthosis Plantar pressures were measured by podobarometric Platform (FREEMED Platform) 90 days after surgery
Secondary Compare daily walk pain kinetics over one month postoperatively in patients requesting palliative solutions at 3 months (requesters) versus those not requesting them (non-requesters) Daily walk pain was measured by questionnaire (Google form) completed by patient every day during 30 days 90 days after surgery